These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10597756)

  • 1. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
    Haffner SM; Alexander CM; Cook TJ; Boccuzzi SJ; Musliner TA; Pedersen TR; Kjekshus J; Pyörälä K
    Arch Intern Med; 1999 Dec 13-27; 159(22):2661-7. PubMed ID: 10597756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The statins in prevention of coronary heart diseases in type 2 diabetics.
    Heljić B; Velija-Asimi Z; Kulić M
    Bosn J Basic Med Sci; 2009 Feb; 9(1):71-6. PubMed ID: 19284399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].
    Heart Protection Study Collaborative Group
    BMC Med; 2005 Mar; 3():6. PubMed ID: 15771782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling total coronary heart disease burden and long-term benefit of cholesterol lowering in middle aged men with and without a history of cardiovascular disease.
    Packard CJ; Young R; Ross K; Ford I; Ambegaonkar BM; Brudi P; McCowan C
    Eur Heart J Qual Care Clin Outcomes; 2017 Oct; 3(4):281-288. PubMed ID: 29044395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity.
    Khalifa A; Guijarro A; Ravera S; Bertola N; Adorni MP; Papotti B; Raffaghello L; Benelli R; Becherini P; Namatalla A; Verzola D; Reverberi D; Monacelli F; Cea M; Pisciotta L; Bernini F; Caffa I; Nencioni A
    Nat Commun; 2023 Oct; 14(1):6951. PubMed ID: 37907500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization patterns of cardiovascular medications in patients with diabetes mellitus; a retrospective cross-sectional study, 2013-17.
    Hatami N; Malekpour MR; Farzadfar F; Seyedifar M; Soleymani F
    Daru; 2023 Dec; 31(2):259-266. PubMed ID: 37848743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Lipid-Lowering Therapy during Cardiac Rehabilitation in Patients with Diabetes Mellitus and Coronary Heart Disease.
    Wittlinger T; Schwaab B; Völler H; Bongarth C; Heinze V; Eckrich K; Guha M; Richter M; Schlitt A
    J Cardiovasc Dev Dis; 2021 Aug; 8(9):. PubMed ID: 34564123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?
    Perreault L; Færch K; Gregg EW
    Curr Diab Rep; 2017 Sep; 17(9):77. PubMed ID: 28766246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American Heart Association Ideal Cardiovascular Health and Incident Type 2 Diabetes Mellitus Among Blacks: The Jackson Heart Study.
    Effoe VS; Carnethon MR; Echouffo-Tcheugui JB; Chen H; Joseph JJ; Norwood AF; Bertoni AG
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28637777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes as "Coronary Artery Disease Risk Equivalent": A Historical Perspective.
    Hajar R
    Heart Views; 2017; 18(1):34-37. PubMed ID: 28584593
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacologic Treatment of Dyslipidemia in Diabetes: A Case for Therapies in Addition to Statins.
    Anabtawi A; Moriarty PM; Miles JM
    Curr Cardiol Rep; 2017 Jul; 19(7):62. PubMed ID: 28528456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study.
    Millán Núñez-Cortés J; Cases Amenós A; Ascaso Gimilio JF; Barrios Alonso V; Pascual Fuster V; Pedro-Botet Montoya JC; Pintó Sala X; Serrano Cumplido A
    Am J Cardiovasc Drugs; 2017 Apr; 17(2):135-142. PubMed ID: 27837448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac autonomic testing and treating heart disease. "A clinical perspective".
    DePace NL; Mears JP; Yayac M; Colombo J
    Heart Int; 2014; 9(2):45-52. PubMed ID: 27004098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE).
    Ishikawa T; Ito H; Ouchi Y; Ohashi Y; Saito Y; Nakamura H; Orimo H; Pate Investigators
    Curr Ther Res Clin Exp; 2005 Jan; 66(1):48-65. PubMed ID: 24672112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessing the benefits of statins in the prevention of cardiovascular disease in diabetic patients--a systematic review and meta-analysis.
    Chang YH; Hsieh MC; Wang CY; Lin KC; Lee YJ
    Rev Diabet Stud; 2013; 10(2-3):157-70. PubMed ID: 24380090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greenselect phytosome for borderline metabolic syndrome.
    Belcaro G; Ledda A; Hu S; Cesarone MR; Feragalli B; Dugall M
    Evid Based Complement Alternat Med; 2013; 2013():869061. PubMed ID: 24348726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial.
    Hermans MP; Elisaf M; Michel G; Muls E; Nobels F; Vandenberghe H; Brotons C;
    Diabetes Care; 2013 Nov; 36(11):3388-95. PubMed ID: 23846810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.
    Steinberg H; Anderson MS; Musliner T; Hanson ME; Engel SS
    Vasc Health Risk Manag; 2013; 9():273-82. PubMed ID: 23761972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and diabetes: the good, the bad, and the unknown.
    Axsom K; Berger JS; Schwartzbard AZ
    Curr Atheroscler Rep; 2013 Feb; 15(2):299. PubMed ID: 23299640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.